FDA Inspection
Celgene CorporationCelgene Corporation – FDA Inspection, Sep 12, 2012
Record Details
This FDA Inspection record concerns Celgene Corporation, with an inspection on September 12, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Celgene Corporation
- Inspection Date
- September 12, 2012
- Product Type
- Drugs
View Company Profile
ID · 72c7c2bb-eda1-4614-9d60-5d6e45996c57
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 798629
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 312.50General responsibilities of sponsors
- 21 CFR 312.50Ensuring compliance with plan and protocol
- 21 CFR 312.57(a)Records of receipt, shipment, disposition
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Celgene Corporation
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 4, 2015 | VAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
| April 28, 2014 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 24, 2013 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 25, 2011 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Celgene Corporation
- FDA Inspection 934610 - 2015-08-04
- FDA Inspection 876766 - 2014-04-28
- FDA Inspection 829461 - 2013-04-24
- FDA Inspection 741664 - 2011-08-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.